Cargando…
Advances in the Cystic Fibrosis Drug Development Pipeline
Cystic fibrosis is a genetic disease that results in progressive multi-organ manifestations with predominance in the respiratory and gastrointestinal systems. The significant morbidity and mortality seen in the CF population has been the driving force urging the CF research community to further adva...
Autores principales: | Esposito, Christine, Kamper, Martin, Trentacoste, Jessica, Galvin, Susan, Pfister, Halie, Wang, Janice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532558/ https://www.ncbi.nlm.nih.gov/pubmed/37763239 http://dx.doi.org/10.3390/life13091835 |
Ejemplares similares
-
THE CLINICAL IMPACT OF COVID-19 ON CYSTIC FIBROSIS PATIENTS IN NEW YORK
por: SIMONSON, JOSEPH, et al.
Publicado: (2021) -
Evolving Nutritional Needs in Cystic Fibrosis
por: Frantzen, Theresa, et al.
Publicado: (2023) -
Future Comorbidities in an Aging Cystic Fibrosis Population
por: Ticona, Javier Humberto, et al.
Publicado: (2023) -
Advancing clinical development pathways for new CFTR modulators in cystic fibrosis
por: Mayer-Hamblett, Nicole, et al.
Publicado: (2016) -
Telemedicine and Its Application in Cystic Fibrosis
por: Fainardi, Valentina, et al.
Publicado: (2023)